SCHEMBL6409612

SCHEMBL6409612

CC1(C)C(COC(c2ccccc2)c2ccccc2)C1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 3/20 0.38
SCN2A Q99250 3/20 0.38
SCN3A Q9NY46 3/20 0.38
ADRA1A P35348 3/20 0.38
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 3/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 2/20 0.38
CYP1A2 P05177 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38
ADRA2A P08913 1/20 0.38
CYP2D6 P10635 1/20 0.38
CHRM1 P11229 1/20 0.38
TSHR P16473 1/20 0.38
ADRA2B P18089 1/20 0.38
CHRM3 P20309 1/20 0.38
SLC6A2 P23975 1/20 0.38
HRH2 P25021 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6406923 0.87 HTT (0.41) SCN1ASCN2ASCN3AADRA1ASLC6A4
SCHEMBL6407668 0.85 TP53 (0.42) LMNAHTTCYP1A2CYP2D6TSHR
SCHEMBL6406470 0.84 CTSK (0.38) SCN1ASCN2ASCN3AADRA1ASLC6A4
SCHEMBL6407755 0.80 CHRM2 (0.41) LMNACYP1A2CHRM2CHRM4CHRM5
SCHEMBL6405926 0.75
SCHEMBL3690693 0.74 TSHR (0.42) SLC6A3LMNATSHRSLC6A2MAPK1
SCHEMBL6521285 0.74 TSHR (0.42) SLC6A3LMNATSHRSLC6A2MAPK1
SCHEMBL1154270 0.74 TSHR (0.42) SLC6A3LMNATSHRSLC6A2MAPK1
SCHEMBL11312924 0.74 TSHR (0.42) SLC6A3LMNATSHRSLC6A2MAPK1
SCHEMBL1150260 0.74 LMNA (0.47) SLC6A3LMNACYP1A2TSHRSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 SCN1A 4712/4885SCN2A 4502/4885SCN3A 4723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.